BLU-945

立即咨询

BLU-945

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

CAS NO:

2660250-10-0

包装与价格：

包装	价格(元)
5mg	电议
10mg	电议

产品介绍

BLU-945 是一种有效的选择性表皮生长因子受体 (EGFR) 抑制剂。EGFR是erbB受体家族的成员，该家族包括跨膜蛋白酪氨酸激酶受体。BLU-945 有效抑制具有 L858R 和/或外显子 19 缺失突变、T790M 突变和 C797S 突变的 EGFR。BLU-945 有助于有效给药并降低 EGFR 介导的靶向毒性。BLU-945 具有研究癌症疾病的潜力 (信息提取自专利 WO2021133809A1，化合物 112)。

Cas No.	2660250-10-0
别名	蓝-945
分子式	C28H37FN6O3S
分子量	556.7
储存条件	Store at -20°C
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
产品描述	receptor (EGFR). EGFR is a member of the erbB receptor family, which includes transmembrane protein tyrosine kinase receptors. BLU-945 effectively inhibits EGFR with L858R and/or exon 19 deletion mutation, T790M mutation, and C797S mutation. BLU-945 facilitates efficacious dosing and reduces EGFR-mediated on-target toxicities. S BLU-945 has the potential for the research of cancer disease (extracted from patent WO2021133809A1, compound 112)[1]. [1]. John Emmerson Campbell, et al. Inhibitors of mutant forms of egfr. Patent WO2021133809A1.